共 50 条
- [32] High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers International Journal of Clinical Oncology, 2012, 17 : 131 - 136
- [35] Implication of polysomy 17 in HER-2/neu overexpressing breast cancers EJC SUPPLEMENTS, 2006, 4 (02): : 146 - 147
- [38] c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant? Breast Cancer Research, 5